Health Care/Hospital
Dizal's Sunvozertinib Approved by China NMPA with Potential for Best-in-class Therapy in NSCLC with EGFR Exon20ins Mutations
* Sunvozertinib, a selective EGFR TKI targeting a wide spectrum of EGFR mutations, is the first Chinese Innovative drug approved for NSCLC Patients with EGFR Exon20ins * Approval based on the results of primary endpoint from WU-KONG6 study, which demonstrated a superior confirmed objective re...
2023-08-23 19:21
742
Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US
Two implants were successfully conducted as part of the FDA approved Early Feasibility Study inthe United States YOKNEAM, Israel, Aug. 23, 2023 /PRNewswire/ -- The heart teams at the Piedmont Heart Institute inAtlanta, Georgia, USA and the University of Virginia Health System inCharlottesville, ...
2023-08-23 18:07
1009
Waterdrop Inc. to Report Second Quarter 2023 Financial Results on September 7, 2023
BEIJING, Aug. 23, 2023 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH
2023-08-23 18:06
2239
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company
MELBOURNE, Australia, Aug. 23, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the half-year ended30 June 2023. All figures are in AUD$ unless otherwise stated.[1] Financial highlights * Total Group revenue $220.8M ...
2023-08-23 17:40
1179
USANA Philippines Celebrates Legacy of Wellness Empowerment With Enterprise Asia Linchpin of Asia Awards 2023
SINGAPORE, Aug. 22, 2023 /PRNewswire/ -- Founded in 1992 by microbiologist and immunologist Dr. Myron Wentz, USANA Health Sciences is a U.S.-based international direct-selling company that researches, manufactures, and sells premium, science-based supplements, personal care, and healthy living...
2023-08-23 17:06
1377
Leading by Inspiration: KPJ Tawakkal KL Specialist Hospital Triumphs with Asia Pacific Enterprise Award for its Exceptional Brand
SINGAPORE, Aug. 23, 2023 /PRNewswire/ -- KPJ Tawakkal KL Specialist Hospital (KPJ TWKL), a renowned name in the healthcare industry, has achieved yet another milestone by being honored with the prestigious Inspirational Brand Award at the Asia Pacific Enterprise Awards 2023 Malaysia. This recogni...
2023-08-23 15:18
1522
Green Living Starts Here: A Look at Practical Steps to Sustainability at Home
PASAY CITY, Philippines, Aug. 23, 2023 /PRNewswire/ -- Managing a household is a fulfilling yet tough, especially when aiming for a more sustainable way of life. Homemakers now understand the significance of living sustainably, not only for the environment but also for their family's health. L...
2023-08-23 14:40
1970
Waterdrop Insurance Marketplace Unveils Blue Ocean LifeTime Health Insurance, Paving the Way for Affordable Premium Healthcare Insurance Solutions
BEIJING, Aug. 23, 2023 /PRNewswire/ -- Waterdrop Insurance Marketplace, the insurance intermediary platform of Waterdrop Inc. ("Waterdrop", the "Company") (NYSE: WDH), a leading technology platform in the insurance and healthcare sectors with an emphasis on social impact, has rolled out Blue Ocea...
2023-08-23 12:12
2583
ImmVira Appoints Howard L. Kaufman, M.D. as Consulting Medical Advisor
SHENZHEN, China, Aug. 22, 2023 /PRNewswire/ -- ImmVira announced to appoint Dr. Howard L. Kaufman as Consulting Medical Advisor. Dr. Kaufman's expertise in scientific research and clinical development, especially in the areas of oncolytic virus and immunotherapy, will greatly enhance ImmVira's re...
2023-08-23 10:51
1484
MGI Partners with NGeneBio to Advance Precision Medicine
SEOUL, South Korea, Aug. 23, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science and NGeneBio, a company specializing in next-generation sequencing-based diagnostic have signed a memorandum of understanding (MOU) to expand the commercial access...
2023-08-23 09:00
2075
Lynk Pharmaceuticals Announces Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Ankylosing Spondylitis
HANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (referred to as "Lynk Pharmaceuticals"), an innovative clinical stage company, announced positive topline data from a Phase II clinical trial of LNK01001 for the treatment of ankylosing spondylitis (AS). The study, led...
2023-08-23 08:00
2440
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results
First patient dosed in a PEG-IFN-α controlled BRII-835 + PEG-IFN-α combination Phase 2 study for HBV functional cure First of several studies to investigate the potential of BRII-179 in enriching patients with strong intrinsic anti-HBsAg responses for curative treatments to start before the end ...
2023-08-22 22:00
2906
Paradigm Therapeutics Acquires Late Stage "Breakthrough Therapy" Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB)
'Topical Therapy for Treating the Wounds and Lesions on the Entire Skin Surface' MT PLEASANT, S.C., Aug. 22, 2023 /PRNewswire/ -- Paradigm Therapeutics Inc., a biopharmaceutical company, today announced the completion of the acquisition of the worldwide rights of SD-101, a topical whole-body trea...
2023-08-22 21:13
1870
Asieris Pharmaceuticals Unveils 2023 Semi-Annual Report, Demonstrating Initial Success of Specialty Pharma Strategy and Multi-Product Synergistic Commercialization
SHANGHAI, Aug. 22, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH) – a global innovative pharmaceutical company specializing in the discovery, development and commercialization of innovative drugs that treat genitourinary (GU) tumors and other related diseases – today release...
2023-08-22 20:58
2031
Sanyou Biopharmaceuticals and Sinorda Biomedicine signed Strategic Cooperation Agreement for Advancing Innovative Drug Research and Development
SHANGHAI, Aug. 22, 2023 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (referred to as "Sanyou" hereafter) and Sinorda Biomedicine (referred to as " Sinorda " hereafter) have officially signed a strategic cooperation agreement to advance the innovative bispecific antibody drug pro...
2023-08-22 20:00
1629
CARsgen Announced 2023 Interim Results
SHANGHAI, Aug. 22, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced its 2023 Interim Results. Business Highlights * Collaboration agr...
2023-08-22 19:30
3123
Ratchaphruek Hospital in Khon Kaen, Thailand Achieves GHA Accreditation with Excellence, Affirming Its World-Class Services for Medical Travelers
KHON KAEN, Thailand, Aug. 22, 2023 /PRNewswire/ -- Ratchaphruek Hospital in Khon Kaen province,Thailand, has achieved a significant milestone by being awarded Accreditation with Excellence for Medical Travel Services byGlobal Healthcare Accreditation (GHA). This accolade underscores Ratchaphruek ...
2023-08-22 18:00
1242
Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
SUZHOU, China, Aug. 22, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has completed the enrollment of 180 patients for the Phase...
2023-08-22 17:13
1128
Berlin Heals Holding AG welcomes Dr. Felix Baader and Roland Diggelmann as new board members Final phase of ongoing CE study started
ZUG, Switzerland, Aug. 22, 2023 /PRNewswire/ -- Berlin Heals Holding AG (Berlin Heals), a Swiss medical technology company, is delighted to announce the appointments of Dr.Felix Baader and Roland Diggelmann as new members of the Board of Directors. Since 2014, the company has developed a complete...
2023-08-22 15:00
1362
Introducing NeoMab™: GemPharmatech's Innovative Antibody Gene Humanized Mouse Model
SAN DIEGO, Aug. 21, 2023 /PRNewswire/ -- GemPharmatech is proud to announce the launch of NeoMab™, our independently developed fully antibody gene humanized mouse model, after four years of rigorous research and validation. NeoMab™ is specifically designed to meet the burgeoning therapeutic antib...
2023-08-22 08:59
1286
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
6686
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
2024-04-22 16:00
4462
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
2024-04-22 06:00
4057
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
3812
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
2024-04-23 15:43
3700